Diminished vasodilation; imbalance of synthesized cyclooxygenase products by adrenergic mediation in diabetic coronaries of the dog.
Koltai
M Z
MZ
National Institute of Cardiology, Budapest, Hungary.
Rösen
P
P
Pogátsa
G
G
D000818:Animals; D003331:Coronary Vessels / Q000187:drug effects / Q000503:physiopathology; D016861:Cyclooxygenase Inhibitors; D003921:Diabetes Mellitus, Experimental / Q000503:physiopathology*; D004285:Dogs; D011464:Epoprostenol / Q000096:biosynthesis; D005260:Female; D000860:Hypoxia / Q000503:physiopathology; D066298:In Vitro Techniques; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism*; D013928:Thromboxane A2 / Q000096:biosynthesis; D014664:Vasodilation / Q000187:drug effects
D016861:Cyclooxygenase Inhibitors; D013928:Thromboxane A2; D011464:Epoprostenol; D011451:Prostaglandin-Endoperoxide Synthases; D009638:Norepinephrine; D010646:Phentolamine